Navigation Links
Gap Introduces Inspirational Marketing Campaign to Celebrate First Anniversary of Global Launch of Gap (PRODUCT) RED
Date:10/3/2007

r Angelina. The campaign also reintroduces a series of images that debuted this summer of Terrence Howard and his three children Hunter, Aubrey and Heaven; Natalie Maines alongside her sons Beckett and Slade; and Abigail Breslin with her friend Curious George.

Developed by Laird + Partners, Gap's creative agency, the print campaign is running in November issues of magazines including Vogue, Vanity Fair, Harper's Bazaar, Elle, Glamour, Lucky, Marie Claire, GQ and Details. The campaign will also appear in The New York Times and weekly magazines including US Weekly, Rolling Stone and Entertainment Weekly. In addition, the campaign will be featured in Gap stores, online, and outdoor in select markets.

As part of Gap's partnership with (PRODUCT) RED, half the profits from Gap's sales of Gap (PRODUCT) RED collections go directly to the Global Fund to help finance AIDS programs in Africa with a focus on women and children. This month, Gap will introduce the (2 WEEKS) T-shirt, a limited edition T-shirt featuring a compelling message about the direct impact that contributions from the sale of this T-shirt will make to the Global Fund. These funds will support programs which provide HIV/AIDS prevention, care and treatment in Africa. Contributions from the sale of the (2 WEEKS) T-shirt are equivalent to the average cost of 2 weeks of antiretroviral (ARV) medicine in Africa which, along with appropriate nutrition and care, enables people living with HIV to lead healthy, normal lives. To celebrate the debut of this special item, Gap's new ad campaign features Anne Hathaway and John Legend wearing the (2 WEEKS) T-shirt. The T-shirt will be available at gap.com beginning Oct. 5 and will be available in select Gap stores nationwide later this month.

One year ago, Gap introduced its first (PRODUCT) RED collection for men and women comprised of items rooted in classic Gap product categories such as T-shirts, hoodies, jeans and accessories. Earlier this year, babyGap
'/>"/>

SOURCE Gap Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. E Merck introduces Livogen Z with zinc sulphate
2. TI Cycles Introduces Foldman
3. Canada Introduces Mandatory Nutrition Labeling
4. Amgen introduces Autoinjector For Treating Anemia
5. Cuba Introduces New Device for Detecting Vascular Diseases
6. China Introduces Solar-powered Baths
7. Allergan Introduces ‘Dermal Filler’ for Smile Lins
8. UAE Introduces Cervical Cancer Vaccine
9. Cynosure Introduces Higher Power Smartlipo(TM) LaserBodySculpting Workstation
10. Iceland Introduces Smoking Ban in Bars and Restaurants
11. Indian Introduces Paan-flavoured Condoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...linical trial results could lead to availability o...eatment for deep lines and wrinkles by 2009. , ... 24, 2008 -- Gel-Del Technologies , a St. Paul, M... that it has concluded clinical trials of CosmetaL...als say holds potential to be a more effective alt...
(Date:7/24/2008)...ll/ --, Key Highlights, Misys plc (LSE: MSY) del...sing targets for the next phase of the turnaround....%, bringing Group operating profit(2) to GBP81m,3...trategy and entering,into the next phase of the tu...o view the Multimedia News Release, please click:,...
(Date:7/23/2008)...wire/ -- MediVoice(R), LLC, the,world,s first mobi...escribing, has formed a strategic partnership with... web-based, patient-centered health record,managem...e and market its,mobile voice-activation solution ...., "MediVoice is pleased to develop a strategic p...
(Date:7/23/2008)..., July 23 /PRNewswire-FirstCall/ - Cardiome Pharma...t it has entered into an,agreement with CR Intrins...,CR Intrinsic Investors, LLC, an affiliate of S.A....ertible preferred shares for gross proceeds of,US$... for general corporate,purposes, costs associated ...
Breaking Medicine News(10 mins):Health News:Clinical Trial Concluded For New Wrinkle Treatment 2Health News:Clinical Trial Concluded For New Wrinkle Treatment 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 2Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 4Health News:MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management System 2Health News:MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management System 3Health News:Cardiome Announces Preferred Share Financing 2Health News:Cardiome Announces Preferred Share Financing 3
.... Ragnfrid H. Nordbo, of the Norwegian Institute o...d set of people// suffering anorexia nervosa, a fo...his mental disease attribute a great deal of impor...a deep seated need or emotion. In his estimate, t...
...n, 81, the famous Pulitzer Prize-winning novelist,...usetts.// According to his daughter, Alexandra, he... He belonged to Virginia. He was obsessive about r...im write novels like "Lie Down In Darkness" and "T...
...a government data, the number of deaths due to alc...The Office for National Statistics (ONS) revealed ... in the year 1991 and it has risen to 8,386 by las...s, the lower price and easy accessibility are resp...
...hich has been one of the major causes of death in ...and in the next two decades// according to the Chi...Dr Harry Burns, "In the 1960s, one in 100 men died...ing all the time and, thanks to the smoking ban, I...
Other Medicine News:Health News:Deaths due to heavy drinking has doubled in 15 years 2Health News:Eradication of Lung Cancer in 20 years 2Health News:Eradication of Lung Cancer in 20 years 3
(Date:7/22/2008)...y and Efficacy of Treating Patients with ...CO, and YONGIN-SI, South Korea, July 22 /PRNewswir..., Ontario), and its South,Korean partner Green Cro...,a Phase I clinical trial of its first-in-class le...s well-tolerated and resulted in clear,anti-cancer...
(Date:7/22/2008)...(R) and Apidra(R) Resulted in Significant, Reducti...ver the Algorithm ... Results from the "Adjust to,Target in Type 2 Diab...rate,Counting for Adjustment of Mealtime Insulin G...abetes Association,s (ADA) medical journal,Diabet...
(Date:7/22/2008)... July 22 /- Hyperion,Therapeutics, In...nrollment,in its Phase 1/2 clinical trial to evalu...g effects of HPN-100 (formally called GT4P) versus...ith urea cycle disorders,(UCD). The company plans ...,of this year., (Logo: http://www.newscom.com/cg...
(Date:7/22/2008)...Columbia University Medical Center Based on ...ogy, The Test Differentiates Squamous From Non-S...ifying Squamous-Cell Carcinoma of the Lung With ...90 Percent,This is the First CLIA Approved Test Wh...iomarkers for Accurate Diagnosis of Lung Cancer, ...
Breaking Medicine Technology:Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5NBTY to Webcast Presentation at Bank of America Consumer Conference 3A Announces Preliminary Sales and the Repurchase of 6 1 Million Shares 13854 1NBTY to Webcast Presentation at Bank of America Consumer Conference 3A Announces Preliminary Sales and the Repurchase of 6 1 Million Shares 13854 2NBTY to Webcast Presentation at Bank of America Consumer Conference 3A Announces Preliminary Sales and the Repurchase of 6 1 Million Shares 13854 3Cepheid to Present at Cowen and Companys 28th Annual Healthcare Conference 3809 1Cepheid to Present at Cowen and Companys 28th Annual Healthcare Conference 3809 2More than Seventy Percent of Top US Hospitals Control Patient Temperature with High Tech Arctic Sun 28TM 29 13849 1More than Seventy Percent of Top US Hospitals Control Patient Temperature with High Tech Arctic Sun 28TM 29 13849 2AVMA 3A Keep Pets Safe This Easter 13847 1AVMA 3A Keep Pets Safe This Easter 13847 2
...w Dissociation from HCV,Protease , ,WASHINGTON, Ma...etwork/ -- InterMune, Inc. (Nasdaq: ITMN) today pr...titis C virus (HCV) NS3/4A,protease inhibitor, ITM...e Disease Week (DDW) meeting being held May 19-24 ...ct #M1816) examined,ITMN-191 potency and binding k...
... FDA for long-term maintenance,treatment of COPD b...ed formoterol fumarate provides improved lung func... patient quality of,life, and positive safety prof... Data presented at the,International Conference of...hat Perforomist (formoterol fumarate) Inhalation,S...
Other Medicine Technology:InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 2InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 3InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 4InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 2Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 3Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 4Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 6Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 7
Anti Gliadin IgA Enzyme Immunosay for quantitative determination of Gliadin-IgG antibodies in serum.
...igned as a high throughput primary or backup instr...r offers performance and reliability equal to or g...advanced technology of the AUTION JET AJ-4270 and ...ate results, limiting interference from elevated p...
Assay uses highly specific rabbit anti-estriol antibody reparation - negligible cross-reactivity with other estrogen metabolites. Excellent assay precision and reproducibility. Superior sensitivity
...rone Sulfate (E1S) is the most abundant circulatin... men [1,2]. Estrone Sulfate is a major metabolite ...fe in blood [2,3]. In premenopausal women, estrone...e and estradiol, rising gradually during the folli...
Medicine Products: